BioSpace News Archive

Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, announced the appointments of Andrew Armanino and Geoffrey Parker to its board of directors.

BrightInsight, Inc., provider of the leading global regulated digital health platform for biopharma and medtech, today announced a Series C financing of $101M led by world-renowned venture capital firm General Catalyst

VolitionRx Limited announced the appointment, effective May 1, 2021, of Dr. Tom Butera DVM, to the position of Chief Executive Officer, Volition Veterinary Diagnostics Development LLC, assuming such role from Dr. Gaetan Michel who continues to serve as Chief Operating Officer of Volition and Chief Executive Officer of Belgian Volition.

Company meets enrollment milestones to support research and development of a new and novel treatment for hard-to-treat cancer

Trinity Biotech plc (Nasdaq: TRIB) has submitted its new HIV screening product, TrinScreen™ HIV, to the World Health Organisation (WHO) for approval.

A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Asher Biotherapeutics for systems pharmacology modeling in solid tumors.

Smiths Medical, a leading medical device manufacturer, announces the release of the ECRI evaluation report for CADD®-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump.

Janux Therapeutics, a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the appointment of Charles Winter as Senior Vice President of Chemistry, Manufacturing, and Controls (CMC)

Glytec, the only provider of insulin management software across the continuum of care, today introduced the latest version of its eGlycemic Management System® (eGMS), including enhancements and new integrations that reduce workflow friction for clinicians and further improve patient safety